These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11945155)

  • 1. The role of protease inhibition with emphasis on the effects of inflammation and vascular immune phenomena.
    Bilfinger TV; Stefano GB
    Curr Pharm Des; 2002; 8(7):505-9. PubMed ID: 11945155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
    Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and pharmacokinetics of LEX 032, a bioengineered serpin: the first of a potential new class of drugs.
    Sands H; Hook JB
    Drug Metab Rev; 1997; 29(1-2):309-28. PubMed ID: 9187523
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.
    Shigetomi H; Onogi A; Kajiwara H; Yoshida S; Furukawa N; Haruta S; Tanase Y; Kanayama S; Noguchi T; Yamada Y; Oi H; Kobayashi H
    Inflamm Res; 2010 Sep; 59(9):679-87. PubMed ID: 20454830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-apoptotic serpins as therapeutics in cardiovascular diseases.
    Kuiper J; Quax PH; Bot I
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
    Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
    Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease Inhibitors in Tick Saliva: The Role of Serpins and Cystatins in Tick-host-Pathogen Interaction.
    Chmelař J; Kotál J; Langhansová H; Kotsyfakis M
    Front Cell Infect Microbiol; 2017; 7():216. PubMed ID: 28611951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine protease inhibitors to treat inflammation: a patent review (2011-2016).
    Soualmia F; El Amri C
    Expert Opin Ther Pat; 2018 Feb; 28(2):93-110. PubMed ID: 29171765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral serine protease inhibitors as anti-atherosclerotic therapy.
    Bot I; van Berkel TJ; Biessen EA
    Curr Opin Investig Drugs; 2007 Sep; 8(9):729-35. PubMed ID: 17729184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral anti-inflammatory reagents: the potential for treatment of arthritic and vasculitic disorders.
    Munuswamy-Ramanujam G; Khan KA; Lucas AR
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):331-43. PubMed ID: 17214579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.
    Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR
    Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of proteinase 3 activity by peptides derived from human epidermis.
    Wiedow O; Lüdemann J; Utecht B; Christophers E
    Adv Exp Med Biol; 1993; 336():61-4. PubMed ID: 8296675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib.
    Sinn DI; Lee ST; Chu K; Jung KH; Kim EH; Kim JM; Park DK; Song EC; Kim BS; Yoon SS; Kim M; Roh JK
    Neurosci Res; 2007 May; 58(1):12-8. PubMed ID: 17328981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
    Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G
    Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease activated receptors: clinical relevance to hemostasis and inflammation.
    Landis RC
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):103-13. PubMed ID: 17258121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases.
    Mkaouar H; Akermi N; Mariaule V; Boudebbouze S; Gaci N; Szukala F; Pons N; Marquez J; Gargouri A; Maguin E; Rhimi M
    Microb Cell Fact; 2016 Nov; 15(1):201. PubMed ID: 27894344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of human elafin.
    Shaw L; Wiedow O
    Biochem Soc Trans; 2011 Oct; 39(5):1450-4. PubMed ID: 21936832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of protease inhibitors in experimental septic shock.
    Siebeck M; Spannagl M; Hoffmann H; Fink E
    Agents Actions Suppl; 1992; 38 ( Pt 3)():421-7. PubMed ID: 1281381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serine protease inhibitors (serpins); regulators of coagulation and inflammation reactions with therapeutic potential].
    Hack CE; Abbink JJ; Nuijens JH
    Ned Tijdschr Geneeskd; 1990 May; 134(21):1035-9. PubMed ID: 2195358
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
    Murohara T; Guo JP; Lefer AM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1246-53. PubMed ID: 7562495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.